| scholarly article | Q13442814 |
| P2093 | author name string | O'Callaghan C | |
| Barry PW | |||
| P2860 | cites work | Drug delivery from holding chambers with attached facemask | Q35628047 |
| Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug | Q41150789 | ||
| Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? | Q41234688 | ||
| Optimum use of a spacer device | Q42129640 | ||
| Large volume plastic spacers in asthma | Q42762009 | ||
| The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols | Q67269146 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 76-78 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler | |
| P478 | volume | 40 |
| Q41593628 | A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices |
| Q41559651 | A comparison of the efficacy and safety of inhaled corticosteroids in asthma |
| Q49600518 | A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC. |
| Q38172855 | Advances in metered dose inhaler technology: hardware development |
| Q46534628 | Aerosol delivery to young children by pMDI-spacer: is facemask design important? |
| Q45105502 | Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers |
| Q35484494 | Aerosol therapy for obstructive lung diseases: device selection and practice management issues |
| Q38162255 | Aerosol therapy in children: challenges and solutions |
| Q33976334 | Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group |
| Q45102142 | Comparison of efficiency and preference of metal and plastic spacers in preschool children |
| Q73641244 | Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma |
| Q41680896 | Delivery of inhaled medication to children |
| Q38941256 | Effect of Spacers on the Bipolar Electrostatic Charge Properties of Metered Dose Inhaler Aerosols-A Case Study With Tilade®. |
| Q36053350 | Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children |
| Q41207776 | Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants |
| Q41207768 | Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device |
| Q74357156 | Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report |
| Q73118634 | Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma |
| Q38126939 | Electrostatics in pharmaceutical aerosols for inhalation |
| Q37643843 | Electrostatics of pharmaceutical inhalation aerosols |
| Q81203084 | Inhalation devices |
| Q33721468 | Inhaled corticosteroids for adult asthma: impact of formulation and delivery device on relative pharmacokinetics, efficacy and safety |
| Q26751471 | Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) |
| Q90029732 | Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations |
| Q41826826 | Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer |
| Q41068716 | Optimizing inhaled drug delivery in patients with asthma |
| Q28346185 | Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge |
| Q50935016 | Randomized trial of spacers in asthma. |
| Q55241851 | Spacer devices for inhaled therapy: why use them, and how? |
| Q37105708 | The challenge of delivering therapeutic aerosols to asthma patients |
| Q35169765 | The influence of inhaler selection on efficacy of asthma therapies |
| Q36815920 | The rejuvenated pressurised metered dose inhaler |
| Q35212195 | Use of inhaler devices in pediatric asthma |
| Q58766885 | Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma |
| Q74674510 | [Controversies in the use of beta-agonists in the treatment of acute asthma] |
Search more.